Biogen (BIIB) Reports Q2 EPS of $1.31; Raises FY10 EPS Outlook
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) reports Q2 EPS of $1.31, versus the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
